TELA Bio Inc. (TELA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TELA Bio Inc.

    NASDAQ: TELA · Real-Time Price · USD
    1.57
    -0.03 (-1.88%)
    At close: Sep 10, 2025, 3:59 PM
    1.57
    0.00%
    After-hours: Sep 10, 2025, 04:10 PM EDT

    TELA Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 69.3M 58.45M 41.42M 29.46M
    Cost of Revenue
    		 22.81M 18.34M 14.37M 10.65M
    Gross Profit
    		 46.49M 40.11M 27.04M 18.81M
    Operating Income
    		 -34.12M -44.08M -39.01M -29.45M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -37.98M -46.66M -44.3M -33.28M
    Net Income
    		 -37.84M -46.66M -44.34M -33.28M
    Selling & General & Admin
    		 79.37M 74.57M 57.11M 41.52M
    Research & Development
    		 8.81M 9.62M 8.94M 6.74M
    Other Expenses
    		 -7.58M n/a n/a n/a
    Operating Expenses
    		 80.6M 84.19M 66.05M 48.26M
    Interest Expense
    		 5.29M 5.22M 4.05M 3.6M
    Selling & Marketing Expenses
    		 64.65M 59.68M 43.25M 29.06M
    Cost & Expenses
    		 103.42M 102.53M 80.42M 58.91M
    Income Tax Expense
    		 -144K n/a 41K 2.83M
    Shares Outstanding (Basic)
    		 28.53M 22.87M 16.27M 14.47M
    Shares Outstanding (Diluted)
    		 28.53M 22.87M 16.27M 14.47M
    EPS (Basic)
    		 -1.33 -2.04 -2.73 -2.3
    EPS (Diluted)
    		 -1.33 -2.04 -2.73 -2.3
    EBITDA
    		 -31.68M -40.63M -39.06M -29.14M
    EBIT
    		 -32.7M -41.44M -40.24M -29.68M
    Depreciation & Amortization
    		 1.01M 808K 1.19M 535K

    Add to Watchlist